News | March 01, 2023
Vaishali Pharma receives multiple orders worth US$ 73.85 million
This order is subject to initial advance payment as per the agreed terms of the contract
This order is subject to initial advance payment as per the agreed terms of the contract
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Twelve hospitals across India will be part of the network which will support the trial in India
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
Subscribe To Our Newsletter & Stay Updated
